Portland health startup MedRhythms grows pipeline with new clinical trial, scientific board

MedRhythms Inc., a Portland health technology startup, is beginning a new clinical trial of the company’s digital therapeutic device for walking impairments related to Parkinson’s disease.

The multisite study will be conducted through a collaboration with Boston University and a leading hospital, and will evaluate the efficacy of the device when used at home, according to a news release.

MedRhythms, launched in 2016, is developing systems with clinical-grade sensors, music and artificial intelligence to measure and improve walking for people with neurological injuries or diseases. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025